(4-(Thiazol-2-ylcarbamoyl)piperidine-1-carbonyl)-L-leucine

• CAT Number: I043102
• CAS Number: 1814897-92-1
• Molecular Formula: C16H24N4O4S
• Molecular Weight: 368.45
• Purity: ≥95%
• Synonyms: (2S)-4-methyl-2-[[4-(1,3-thiazol-2-ylcarbamoyl)piperidine-1-carbonyl]amino]pentanoic acid
• InChI: InChI=1S/C16H24N4O4S/c1-10(2)9-12(14(22)23)18-16(24)20-6-3-11(4-7-20)13(21)19-15-17-5-8-25-15/h5,8,10-12H,3-4,6-7,9H2,1-2H3,(H,18,24)(H,22,23)(H,17,19,21)/t12-/m0/s1
• InChIKey: XXKUWDIUUZIARI-LBPRGKRZSA-N
• SMILES: CC(C)C[C@@H](C(=O)O)NC(=O)N1CCC(CC1)C(=O)NC2=NC=CS2

(4-(Thiazol-2-ylcarbamoyl)piperidine-1-carbonyl)-L-leucine（Cat No.:I043102）is a peptidomimetic compound used in pharmaceutical research, drug discovery, and enzyme inhibition studies. The thiazolylcarbamoyl moiety provides bioactivity and binding specificity, while the piperidine core contributes to rigidity and metabolic stability. As an L-leucine-conjugated derivative, it plays a role in peptide-based drug design, protease inhibition, and receptor-targeting therapeutics. This compound is particularly valuable in medicinal chemistry, structural biology, and metabolic pathway research, making it a key candidate for developing bioactive peptides, enzyme inhibitors, and small-molecule therapeutics with enhanced pharmacokinetic properties.